MAPT and neurodegenerative disease: For investigation of the relationship between vermal tau-PET signals and specific neurodegenerative diseases, we separated all participants into four cohorts with 3/4R-tauopathies, 4R-tauopathies, tau-negative disease controls and healthy controls.